Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

17.6%

3 terminated/withdrawn out of 17 trials

Success Rate

78.6%

-7.9% vs industry average

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

64%

7 of 11 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

N/A
5(45.5%)
Phase 3
3(27.3%)
Phase 2
2(18.2%)
Phase 4
1(9.1%)
11Total
N/A(5)
Phase 3(3)
Phase 2(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT06456554Not ApplicableRecruiting

Acellular Dermal Matrix Investigation in Breast Reconstruction

Role: lead

NCT07118020Enrolling By Invitation

Post Market Study of Tutopatch In Craniotomy

Role: lead

NCT06101979Enrolling By Invitation

A Prospective Study of Fortiva in Hernia Repair

Role: lead

NCT02587403Not ApplicableCompleted

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

Role: lead

NCT03744013Not ApplicableCompleted

A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis

Role: lead

NCT02891759Phase 2Completed

Compare Outcomes Between Two Acellular Dermal Matrices

Role: collaborator

NCT00975845Completed

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

Role: lead

NCT02628210Not ApplicableCompleted

Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion

Role: lead

NCT04171544Completed

Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up

Role: lead

NCT02586116Not ApplicableCompleted

Comparison of nanOss Cervical IBF System to C-Plus PEEK IBF Device With Autograft

Role: lead

NCT03699891Completed

Evaluation of the Fortilink IBF System With TETRAfuse Technology

Role: lead

NCT00659880Completed

Clinical Application of BioCleanse Meniscus

Role: lead

NCT02161016Phase 4Terminated

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

Role: lead

NCT00984594Phase 3Terminated

Evaluation of a Composite Cancellous and Demineralized Bone Plug (CR-Plug) for Repair of Knee Osteochondral Defects

Role: lead

NCT00793104Phase 3Terminated

Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee.

Role: lead

NCT00821873Phase 3Completed

Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee.

Role: lead

NCT00255970Phase 2Completed

Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects

Role: lead

All 17 trials loaded